United States

Miraca Holdings Inc (4544.T)

4544.T on Tokyo Stock Exchange

2:00am EDT
Change (% chg)

¥0 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Miraca Holdings Inc. is a Japan-based holding company. The Company operates in three business segments. The Clinical Diagnostic segment is engaged in the manufacture and sale of clinical diagnostics. The Entrusted Clinical Examination segment is involved in the special clinical examination, the general clinical examination, as... (more)


Beta: 0.58
Market Cap(Mil.): ¥298,085.09
Shares Outstanding(Mil.): 57.32
Dividend: 65.00
Yield (%): 2.19


  Industry Sector
P/E (TTM): -- 91.81 16.83
EPS (TTM): -- -- --
ROI: -- 2.42 10.92
ROE: -- 3.28 14.52

BRIEF-Avista Capital Partners to acquire Miraca Life Sciences

* Avista Capital Partners says ‍Miraca Life Sciences is a wholly-owned subsidiary of Miraca Holdings Inc​ Source text for Eikon: Further company coverage:

Sep 22 2017

BRIEF-Miraca Holdings says business transfer between two units

* Says a Tokyo-based wholly owned unit FRHD will take over the subsidiary management business from its unit FUJIREBIO Inc., on July 1

May 11 2017

BRIEF-R&I affirms Miraca Holdings's rating at "A" and says stable outlook-R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A"-R&I

Apr 17 2017

Earnings vs. Estimates